[go: up one dir, main page]

PE20091718A1 - (pirazolilcarbonil) imidazolidinonas sustituidas con actividad antiviral - Google Patents

(pirazolilcarbonil) imidazolidinonas sustituidas con actividad antiviral

Info

Publication number
PE20091718A1
PE20091718A1 PE2009000388A PE2009000388A PE20091718A1 PE 20091718 A1 PE20091718 A1 PE 20091718A1 PE 2009000388 A PE2009000388 A PE 2009000388A PE 2009000388 A PE2009000388 A PE 2009000388A PE 20091718 A1 PE20091718 A1 PE 20091718A1
Authority
PE
Peru
Prior art keywords
antiviral activity
imidazolidin
ona
carbonyl
chloro
Prior art date
Application number
PE2009000388A
Other languages
English (en)
Inventor
Kai Thede
Susanne Greschat
Steffen Wildum
Daniela Paulsen
Original Assignee
Aicuris Gmbh And Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh And Co Kg filed Critical Aicuris Gmbh And Co Kg
Publication of PE20091718A1 publication Critical patent/PE20091718A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REFERIDA A UN DERIVADO DE (PIRAZOLILCARBONIL)IMIDAZOLIDINONA DE FORMULA (I), DONDE R1 ES FENILO OPCIONALMENTE SUSTITUIDO POR HALOGENO, HIDROXI, CIANO, NITRO, TRIFLUOROMETILO, TRIFLUROMETOXI, ENTRE OTROS; R2 ES FENILO OPCIONALMENTE SUSTITUIDO POR HALOGENO, HIDROXI, CIANO, NITRO, TRIFLUOROMETILO, TRIFLUOROMETILTIO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-{[1-(3-CLORO-4-FLUOROFENIL)-5-(3-CLORO-5-FLUOROFENIL)-1H-PIRAZOL-3-IL]CARBONIL}IMIDAZOLIDIN-4-ONA, 1-{[5-(3-CLORO-5-FLUROFENIL)-1-(3-CLOROFENIL)-1H-PIRAZOL-3-IL]CARBONIL}IMIDAZOLIDIN-4-ONA, 1-{[1-(3-CLOROFENIL)-5-(3,5-DIFLUOROFENIL)-1H-PIRAZOL-3-IL]CARBONIL}IMIDAZOLIDIN-4-ONA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTIVIRAL Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES RETROVIRALES COMO EL VIH
PE2009000388A 2008-03-17 2009-03-17 (pirazolilcarbonil) imidazolidinonas sustituidas con actividad antiviral PE20091718A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008015033A DE102008015033A1 (de) 2008-03-17 2008-03-17 Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung

Publications (1)

Publication Number Publication Date
PE20091718A1 true PE20091718A1 (es) 2009-12-11

Family

ID=40565083

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000388A PE20091718A1 (es) 2008-03-17 2009-03-17 (pirazolilcarbonil) imidazolidinonas sustituidas con actividad antiviral

Country Status (22)

Country Link
US (1) US8399682B2 (es)
EP (1) EP2254885B1 (es)
JP (1) JP5576853B2 (es)
KR (1) KR20100124337A (es)
CN (1) CN101977908B (es)
AP (1) AP2774A (es)
AR (1) AR070919A1 (es)
AU (1) AU2009226656A1 (es)
CA (1) CA2718685C (es)
CL (1) CL2009000636A1 (es)
DE (1) DE102008015033A1 (es)
IL (1) IL207649A0 (es)
MA (1) MA32224B1 (es)
MX (1) MX2010010230A (es)
NZ (1) NZ588141A (es)
PE (1) PE20091718A1 (es)
RU (1) RU2010141578A (es)
TW (1) TW200951125A (es)
UA (1) UA102390C2 (es)
UY (1) UY31717A1 (es)
WO (1) WO2009115213A1 (es)
ZA (1) ZA201007361B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
EP2295038B1 (en) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Solid dispersion comprising an anti-HIV agent
DE102011055815A1 (de) * 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB453061A (en) 1935-03-23 1936-09-04 Charles Howard Twigg Improvements in and relating to gas heated geysers and water heaters
US3806506A (en) * 1971-08-05 1974-04-23 Uniroyal Inc Furan derivatives,compositions thereof and methods for using same
DE3119796A1 (de) 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5571810A (en) * 1990-06-11 1996-11-05 Fujisawa Pharmaceutical Co., Ltd. Thiophene derivatives
GB9012936D0 (en) 1990-06-11 1990-08-01 Fujisawa Pharmaceutical Co Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
IL104311A (en) 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
JPH084281B2 (ja) * 1992-09-30 1996-01-17 橋本コーポレイション株式会社 オンフック後相手の声を拡声する電話装置
FR2728571B1 (fr) * 1994-12-22 1997-01-31 Adir Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5696151A (en) 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
US6143780A (en) * 1999-09-17 2000-11-07 Uniroyal Chemical Company, Inc. N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV
DE60133897D1 (de) 2000-06-28 2008-06-19 Astrazeneca Ab Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
GB0113524D0 (en) * 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
DE60208683T2 (de) 2001-08-01 2006-11-02 Basell Polyolefine Gmbh Verfahren zur herstellung von heterocyclischen pentalen derivaten
AU2002363250A1 (en) 2001-11-01 2003-05-12 Icagen, Inc. Pyrazole-amides and-sulfonamides
US7005432B2 (en) 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
US7166619B2 (en) * 2002-08-14 2007-01-23 Ppd Discovery , Inc. Prenylation inhibitors and methods of their synthesis and use
GB0221477D0 (en) * 2002-09-16 2002-10-23 Pfizer Ltd Chemical compounds
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
CA2505945A1 (en) 2002-12-02 2004-06-17 Fujisawa Pharmaceutical Co., Ltd. Pyrazole derivatives useful as cox-i inhibitors
US7622471B2 (en) * 2003-02-07 2009-11-24 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives having a pyridazine and pyridine functionality
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
WO2004076453A1 (en) 2003-02-27 2004-09-10 Neurosearch A/S Novel diazabicyclic aryl derivatives
FR2856683A1 (fr) 2003-06-25 2004-12-31 Sanofi Synthelabo Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
DK1641764T3 (da) * 2003-06-26 2011-11-21 Novartis Ag P38-kinasehæmmere på grundlag af 5-leddede heterocykliske forbindelser
GB0315657D0 (en) * 2003-07-03 2003-08-13 Astex Technology Ltd Pharmaceutical compounds
WO2005007625A2 (en) 2003-07-14 2005-01-27 The University Of Tennessee Research Foundation Heterocyclic amides with anti-tuberculosis activity
US7220772B2 (en) * 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
FR2860792B1 (fr) 2003-10-10 2006-02-24 Sanofi Synthelabo Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique
US20090149463A1 (en) 2004-02-20 2009-06-11 Leifeng Cheng Therapeutic agents
US20080064682A1 (en) * 2004-07-01 2008-03-13 Daiichi Pharmaceutical Co., Ltd. Pyrazole Derivatives
GB0417910D0 (en) 2004-08-11 2004-09-15 Novartis Ag Organic compounds
WO2006023462A1 (en) 2004-08-23 2006-03-02 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
DE102004054666A1 (de) 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
EP1824843A2 (en) 2004-12-07 2007-08-29 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
WO2006062982A2 (en) 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Urea inhibitors of map kinases
MX2007006743A (es) 2004-12-15 2007-07-09 Astrazeneca Ab Ligandos del receptor de acetilcolina nicotinica.
PE20061067A1 (es) 2005-03-10 2006-11-30 Bayer Pharmaceuticals Corp Derivados de pirimidina
CA2613517A1 (en) 2005-06-27 2007-01-04 Exelixis, Inc. Pyrazole based lxr modulators
WO2007009701A2 (en) 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
EP1743637A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
GB0516661D0 (en) 2005-08-13 2005-09-21 Astrazeneca Ab Therapeutic agents
ES2339998T3 (es) 2006-10-12 2010-05-27 Janssen Pharmaceutica Nv Derivados de pirazinona sustituidos para uso como medicamento.
WO2008080056A2 (en) 2006-12-21 2008-07-03 Sloan-Kettering Institute For Cancer Research Pyridazinones and furan-containing compounds
GB0701426D0 (en) 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung

Also Published As

Publication number Publication date
AR070919A1 (es) 2010-05-12
CL2009000636A1 (es) 2010-05-07
EP2254885A1 (de) 2010-12-01
UY31717A1 (es) 2009-08-31
KR20100124337A (ko) 2010-11-26
US8399682B2 (en) 2013-03-19
ZA201007361B (en) 2011-12-28
US20110124618A1 (en) 2011-05-26
MA32224B1 (fr) 2011-04-01
CA2718685C (en) 2016-11-29
JP5576853B2 (ja) 2014-08-20
UA102390C2 (ru) 2013-07-10
DE102008015033A1 (de) 2009-09-24
IL207649A0 (en) 2010-12-30
CN101977908B (zh) 2014-04-23
JP2011514366A (ja) 2011-05-06
AP2774A (en) 2013-09-30
RU2010141578A (ru) 2012-04-27
CA2718685A1 (en) 2009-09-24
EP2254885B1 (de) 2013-12-04
MX2010010230A (es) 2010-11-09
TW200951125A (en) 2009-12-16
AU2009226656A1 (en) 2009-09-24
NZ588141A (en) 2012-05-25
CN101977908A (zh) 2011-02-16
AP2010005422A0 (en) 2010-10-31
WO2009115213A1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
PE20091718A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas con actividad antiviral
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
PE20210642A1 (es) Inhibidores de pd-1/pd-l1
PE20080927A1 (es) Derivados de benzoil-amino-heterociclilo como activadores de la glucoquinasa (glk)
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20120002A1 (es) Derivados de benceno sustituido con glucopiranosilo como inhibidores de sglt2
PE20081850A1 (es) Derivados ciclizados como inhibidores de la eg-5
PE20090160A1 (es) COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20140244A1 (es) Composicion farmaceutica, metodos de tratamiento y usos de la misma
PE20080890A1 (es) DERIVADOS DE IMIDAZOLONA E IMIDAZOLIDINONA COMO INHIBIDORES DE LA 11b-HSD1 PARA LA DIABETES
PA8614301A1 (es) Derivados de tropano
ECSP088863A (es) Compuestos que son agonistas de receptores muscarínicos y que pueden ser eficaces en el tratamiento del dolor, la enfermedad de alzheimer y/o la esquizofrenia
PE20081315A1 (es) Derivados de benzimidazol como antagonistas de vr-1
PE20110298A1 (es) Derivados de picolinamida como inhibidores de cinasa
CL2008001946A1 (es) Compuestos derivados de imidazol, antagonistas de receptores ccr2, ccr3, ccr5; procedimiento de preparacion; y uso en el tratamiento de enfermedades vasculares perifericas.
CR8759A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores quimioquinas
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
PE20142301A1 (es) Uracilos sustituidos biciclicamente y uso de los mismos
ATE430743T1 (de) Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken
PE20060691A1 (es) Serinamidas sustituidas por benzoilo
PE20071112A1 (es) Derivados azufrados de urea ciclica como inhibidores de quinasas y su preparacion
PE20091653A1 (es) Derivados sustituidos de pirazol y su uso
PE20110433A1 (es) Antagonistas de la via hedgehog de ftalazina disustituida
ECSP10010428A (es) Derivados de indazol

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed